EUA
MAWD Laboratories SARS-CoV-2 Dual Target by RT-PCR
FDA Emergency Use Authorization · MAWD Laboratories · Oct 13, 2023
Key facts
| Product | MAWD Laboratories SARS-CoV-2 Dual Target by RT-PCR |
|---|---|
| Company | MAWD Laboratories |
| Product type | real-time RT-PCR, Multiple Targets |
| Date | Oct 13, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: